Literature DB >> 17053645

Reliability of the gross motor function measure for children with osteogenesis imperfecta.

J Ruck-Gibis1, H Plotkin, J Hanley, S Wood-Dauphinee.   

Abstract

PURPOSE: The Gross Motor Function Measure (GMFM) is a criterion-referenced evaluative measure designed to detect change over time for children diagnosed with cerebral palsy (CP). Reliability of this measure has not been tested for children with osteogenesis imperfecta (OI). The purpose of this study was to determine the intra- and interrater reliabilities of the GMFM for use with children diagnosed with OI.
METHOD: One physical therapist administered and scored the GMFM for 19 children with OI who were followed at the Shriners Hospital for Children. The assessments were videotaped, then viewed and scored by five physical therapists, including the author, at least six weeks later. Intra- and interrater reliabilities were assessed using intraclass correlation coefficients (ICCs). Kappa statistics were calculated for items demonstrating more disagreement than the majority.
RESULTS: The ICCs for intrarater reliability of the five dimensions and total score were 0.99. The ICCs for interrater reliability were 0.98 for the lying and rolling dimension and 0.99 for the other dimensions and total score. Kappa statistics for items demonstrating more disagreement than the majority ranged from 0.552 to 1.00.
CONCLUSIONS: This study provides evidence of the reliability of the GMFM for children with OI when scored by pediatric physical therapists familiar with the measure. The videotape provided a consistent situation because each therapist did not directly interact with each child, but rather rated a videotaped session of the child's performance.

Entities:  

Year:  2001        PMID: 17053645

Source DB:  PubMed          Journal:  Pediatr Phys Ther        ISSN: 0898-5669            Impact factor:   3.049


  13 in total

1.  Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year.

Authors:  Joanne Ruck; Noémi Dahan-Oliel; Kathleen Montpetit; Frank Rauch; François Fassier
Journal:  J Child Orthop       Date:  2011-05-08       Impact factor: 1.548

2.  Neuromuscular training based on whole body vibration in children with spina bifida: a retrospective analysis of a new physiotherapy treatment program.

Authors:  C Stark; H-K Hoyer-Kuhn; O Semler; L Hoebing; I Duran; R Cremer; E Schoenau
Journal:  Childs Nerv Syst       Date:  2014-11-05       Impact factor: 1.475

3.  Interdisciplinary Care Improves Functional Mobility in an Individual with Type IX Osteogenesis Imperfecta.

Authors:  Lisa C Drefus; Sandra Cassady; Cathleen L Raggio
Journal:  HSS J       Date:  2015-01-27

Review 4.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

5.  How brachial plexus birth palsy affects motor development and upper extremity skill quality?

Authors:  Gülay Çelik; Tüzün Fırat
Journal:  Childs Nerv Syst       Date:  2021-07-01       Impact factor: 1.475

6.  A scoring system for the assessment of clinical severity in osteogenesis imperfecta.

Authors:  Mona S Aglan; Laila Hosny; Rasha El-Houssini; Sawsan Abdelhadi; Fadia Salem; Rokia A S Elbanna; Seham A Awad; Moushira E Zaki; Samia A Temtamy
Journal:  J Child Orthop       Date:  2012-02-08       Impact factor: 1.548

7.  Child abuse and osteogenesis imperfecta: how can they be still misdiagnosed? A case report.

Authors:  Patrizia D'Eufemia; Marta Palombaro; Valentina Lodato; Anna Zambrano; Mauro Celli; Pietro Persiani; Maria Pia De Bari; Luca Sangiorgi
Journal:  Clin Cases Miner Bone Metab       Date:  2012-12-20

8.  Reliability of the Brazilian Portuguese version of the Gross Motor Function Measure in children with cerebral palsy.

Authors:  Kênnea M Almeida; Karolina A Albuquerque; Marina L Ferreira; Stéphany K B Aguiar; Marisa C Mancini
Journal:  Braz J Phys Ther       Date:  2016-01-19       Impact factor: 3.377

9.  Factors Influencing the Gross Motor Outcome of Intensive Therapy in Children with Cerebral Palsy and Developmental Delay.

Authors:  Bo Young Hong; Leechan Jo; Joon Sung Kim; Seong Hoon Lim; Jung Min Bae
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

10.  Safety and efficacy of denosumab in children with osteogenesis imperfect--a first prospective trial.

Authors:  H Hoyer-Kuhn; J Franklin; G Allo; M Kron; C Netzer; P Eysel; B Hero; E Schoenau; O Semler
Journal:  J Musculoskelet Neuronal Interact       Date:  2016-03       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.